Jie Dai

机构：Tongji University, Guizhou Center for Disease Control and Prevention, Shanghai Pulmonary Hospital · ORCID：0000-0003-4316-4243

发表论文 189 篇 · 总被引 3684 次 · h-index 30

代表论文

• Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial (2025 · Nature Communications · 被引 15)
• Tumor therapeutics in the era of “RECIST”: past, current insights, and future prospects (2024 · Oncology Reviews · 被引 13)
• Effect of NLRP3 Inflammasome on Lung Cancer Immune Microenvironment Activation and Its Mechanism. (2024 · PubMed · 被引 6)
• Multiplexing and massive parallel sequencing of targeted DNA methylation to predict chronological age (2025 · Frontiers in Aging · 被引 5)
• Efficiently Reversing Immunotherapy Resistance in Lung Cancer by an Inhalable 2D Molybdenum Disulfide T Cell Hyperactivation Platform (2025 · ACS Nano · 被引 3)
• Sinus Bone Graft Stability and Implant Survival Following Transalveolar Sinus Floor Elevation in Severely Atrophic Maxilla: A Retrospective Study With 5–8 Years of Follow‐Up (2024 · Clinical Oral Implants Research · 被引 3)